US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Renaissance Technologies Holdings

1,842.97

-69.3490-3.63%

Number of Gainers:43

Number of Losers:53

Number of Flat:- -

PE:- -

High:1,912.48

Open:1,912.48

Low:1,840.23

Close:1,912.72

Loading ...

MrBeast Raising $200M At $5B Valuation To Expand Empire—From Feastables To Viral Videos, His Business Is Booming

Smith & Wesson Brands, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Simply Wall St.

3 Magnificent Growth Stocks to Buy in March

US Secretary of Health Kennedy to meet food company chiefs next week, Politico reports

Fortis' (TSE:FTS) investors will be pleased with their respectable 49% return over the last five years

Simply Wall St.

BRIEF-Incyte Corp Says Phase 3 True-Pn1 Study Meets All Primary And Key Secondary Endpoints

BRIEF-Bristol Myers Squibb Says Sotyktu Well-Tolerated Compared To Placebo And Apremilast

J&J - Icotrokinra Results Show Potential to Set a New Standard of Treatment in Plaque Psoriasis

THOMSON REUTERS

J&J - Phase 3 Iconic-Advance 1&2(E )Studies Met Their Co-Primary Endpoints

THOMSON REUTERS

Snowflake’s Stock Dips Amidst AI Expansion

Moderna’s Stock Soars Amid Insider Confidence

CrowdStrike Holdings Faces Stock Dip Amid Strong Earnings

Incyte - Topline Data From Separate Phase 3 Study, True-Pn2, Showed That Primary Endpoint Did Not Reach Statistical Significance

THOMSON REUTERS

Incyte Corp - Phase 3 True-Pn1 Study Meets All Primary and Key Secondary Endpoints

THOMSON REUTERS

Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients With Prurigo Nodularis (Pn) at 2025 American Academy of Dermatology Annual Meeting

THOMSON REUTERS

Bristol Myers Squibb Presents Late-Breaking Data From Phase 3 Poetyk Psa-2 Trial Demonstrating Superiority of Sotyktu (Deucravacitinib) Compared With Placebo in Adults With Psoriatic Arthritis

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/BK4532/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4532"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","market":"US","secType":"PLATE","nameCN":"Renaissance Technologies Holdings","latestPrice":1843.3723,"timestamp":1741626860654,"preClose":1912.7213,"halted":0,"volume":658226427,"delay":0,"changeRate":-0.036257,"change":-69.348999,"pbRate":8.603584,"amount":77360237711.07117,"amplitude":0.037772,"prevYearClose":2026.1482,"fiveDayClose":1911.3298,"twentyDayClose":2013.1425,"turnoverRate":0.005116,"marketCap":20573367042592,"floatMarketCap":19237641641632,"peRate":31.475371},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","high":1912.4766,"amplitude":0.037772,"preClose":1912.7213,"low":1840.23,"pbRate":"8.603584","latestPrice":1842.9711,"volume":658126439,"delay":0,"open":1912.4766,"prevYearClose":2026.1482,"prevWeekClose":1912.7213,"prevMonthClose":1965.7411,"prevQuarterClose":2026.1482,"fiveDayClose":1911.3298,"twentyDayClose":2013.1425,"sixtyDayClose":2078.4277,"secType":"PLATE","market":"US","turnoverRate":0.005116,"peRate":31.475371,"marketCap":20569742880800,"floatMarketCap":19234249898656,"timestamp":1741626857531,"nameCN":"Renaissance Technologies Holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4532\",,,,undefined,":{"bkCode":"BK4532","up":43,"down":53,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4532\",pageSize:16,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517442783","title":"MrBeast Raising $200M At $5B Valuation To Expand Empire—From Feastables To Viral Videos, His Business Is Booming","url":"https://stock-news.laohu8.com/highlight/detail?id=2517442783","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517442783?lang=en_us&edition=fundamental","pubTime":"2025-03-08 23:00","pubTimestamp":1741446043,"startTime":"0","endTime":"0","summary":"YouTube sensation MrBeast—Jimmy Donaldson—has been quietly discussing a major funding round that could peg his holding company at roughly $5 billion. According to Bloomberg, his various ventures, including Feastables, Lunchly, and his video production outfit, generated over $400 million in sales last year.With his channel boasting over 368 million subscribers and YouTube pulling in roughly $31.5 billion in ad revenue in 2024, the scale is hard to ignore.MrBeast's reputation rests on creating high-impact content—from massive giveaways to jaw-dropping challenges—that continues to capture audiences worldwide.‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.26/share with a $1000 minimum.Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — this is your last chance to become an investor for $0.80 per share today.Amazon  backed the first se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mrbeast-raising-200m-5b-valuation-150043426.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BYQQ9H92.USD","LU0157215616.USD","LU1934455277.USD","LU2237957902.USD","LU0823411888.USD","LU1988902786.USD","LU2357305700.SGD","LU0354030438.USD","LU0048584097.USD","LU0889565833.HKD","BK4532","LU0097036916.USD","IE00BJLML261.HKD","LU0130103400.USD","LU2087625088.SGD","IE0034235303.USD","SGXZ81514606.USD","LU1316542783.SGD","USAW.SI","LU0130102774.USD","LU1934455863.HKD","LU1153585028.USD","LU1366192091.USD","SG9999014906.USD","SG9999015945.SGD","LU1366333091.USD","LU0345769631.USD","LU1989764664.SGD","LU1861127337.USD","LU1718418525.SGD","LU0096362180.USD","LU0957791311.USD","GB00BDT5M118.USD","LU2552382215.SGD","LU2247934214.USD","AMZN","IE0004445239.USD","LU2461242641.AUD","BK4548","BK4596","BZFD","LU1046421795.USD","LU0109391861.USD","LU1069344957.HKD","LU0203202063.USD","SG9999015952.SGD","LU0072462426.USD","LU1119994496.HKD","LU2089283258.USD","BK4579"],"gpt_icon":1},{"id":"2518424136","title":"Smith & Wesson Brands, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions","url":"https://stock-news.laohu8.com/highlight/detail?id=2518424136","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518424136?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:44","pubTimestamp":1741445083,"startTime":"0","endTime":"0","summary":"Shareholders might have noticed that Smith & Wesson Brands, Inc. ( NASDAQ:SWBI ) filed its quarterly result this time...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/4121000-choice2-main-header/1585186962234","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4121000-choice2-main-header/1585186962234"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-durables/nasdaq-swbi/smith-wesson-brands/news/smith-wesson-brands-inc-just-beat-analyst-forecasts-and-anal","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SWBI","BK4190","SWHC","BK4532"],"gpt_icon":0},{"id":"2517473334","title":"3 Magnificent Growth Stocks to Buy in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2517473334","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517473334?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:41","pubTimestamp":1741444860,"startTime":"0","endTime":"0","summary":"Eli Lilly is one of the top growth stocks in the pharmaceutical industry.Amgen could tap into more growth opportunities by entering the GLP-1 market.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/08/3-magnificent-growth-stocks-to-buy-in-march/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["IE00BJJMRZ35.SGD","LU0757428866.USD","BK4585","IE00B19Z3581.USD","LU0256863811.USD","LU0889565916.HKD","BK4533","LU2462157665.USD","LU2236285917.USD","LU0320765992.SGD","IE0002141913.USD","IE00BZ9MQY76.HKD","IE00B4R5TH58.HKD","LU0061475181.USD","LU2417539215.USD","LU2362540622.SGD","LU1035775433.USD","BK4588","IE00BJT1NW94.SGD","IE00B19Z9P08.USD","LU1093756168.USD","LU1815336091.USD","LU1585245621.USD","LU0823416689.USD","IE0002270589.USD","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU2324357040.USD","LU2362541513.USD","BK4139","VRTX","BK4532","IE00B19Z9Z06.USD","LU0109394709.USD","LU0566484027.USD","LU2237438978.USD","VERX","LU1430594728.SGD","BK4093","IE0009355771.USD","IE00B19Z3B42.SGD","IE00B894F039.SGD","BK4023","LU1093756325.SGD","BK4567","LU2456880835.USD","CF","LU1559883803.SGD","LU0079474960.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2517444432","title":"US Secretary of Health Kennedy to meet food company chiefs next week, Politico reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2517444432","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517444432?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:35","pubTimestamp":1741444541,"startTime":"0","endTime":"0","summary":"US Secretary of Health Kennedy to meet food company chiefs next week, Politico reportsMarch 8 (Reuters) - U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. plans to meet with senior ex","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250308:nL4N3PR015:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU1244550221.USD","IE00B3T34201.USD","LU0234572021.USD","BK4581","PEP","LU1244550577.SGD","LU1894683348.USD","LU0098860793.USD","BK4504","BK4550","LU1929549753.HKD","BK4588","LU0320765646.SGD","LU1894683264.USD","LU1430594728.SGD","BK4212","BK4177","BK4585","LU1585245621.USD","LU1244550494.USD","LU1162221912.USD","LU1989763427.SGD","BK4532","BK4534","BK4533","GIS","LU1989763690.USD"],"gpt_icon":0},{"id":"2517446994","title":"Fortis' (TSE:FTS) investors will be pleased with their respectable 49% return over the last five years","url":"https://stock-news.laohu8.com/highlight/detail?id=2517446994","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517446994?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:09","pubTimestamp":1741442993,"startTime":"0","endTime":"0","summary":"When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd like to see the share price move up more than the market average. But Fortis Inc.  has fallen short of that second goal, with a share price rise of 23% over five years, which is below the market return. Zooming in, the stock is up a respectable 19% in the last year.So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fortis-tse-fts-investors-pleased-140953024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","TSE","BK4090","BK4081","FTS"],"gpt_icon":0},{"id":"2517144198","title":"BRIEF-Incyte Corp Says Phase 3 True-Pn1 Study Meets All Primary And Key Secondary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2517144198","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517144198?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:08","pubTimestamp":1741442903,"startTime":"0","endTime":"0","summary":"BRIEF-Incyte Corp Says Phase 3 True-Pn1 Study Meets All Primary And Key Secondary EndpointsMarch 8 (Reuters) - Incyte Corp INCY.O:INCYTE ANNOUNCES RESULTS OF PHASE 3 CLINICAL TRIALS EVALUATING RUXOLIT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250308:nTUA40P8T6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4550","BK4585","BK4588","INCY","BK4532"],"gpt_icon":0},{"id":"2517441150","title":"BRIEF-Bristol Myers Squibb Says Sotyktu Well-Tolerated Compared To Placebo And Apremilast","url":"https://stock-news.laohu8.com/highlight/detail?id=2517441150","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517441150?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:08","pubTimestamp":1741442896,"startTime":"0","endTime":"0","summary":"BRIEF-Bristol Myers Squibb Says Sotyktu Well-Tolerated Compared To Placebo And ApremilastMarch 8 (Reuters) - Bristol-Myers Squibb Co BMY.N:BRISTOL MYERS SQUIBB PRESENTS LATE-BREAKING DATA FROM PHASE 3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250308:nTUA3WWKR9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","LU0237698245.USD","LU1670710661.SGD","LU1670711040.USD","BK4532","LU0096364046.USD","IE00BFXG1179.USD","BK4534","LU0456855351.SGD","BK4588","LU0114720955.EUR","LU0306807586.USD","LU1093756168.USD","LU0321505868.SGD","LU1430594728.SGD","LU1670710588.SGD","LU0321505439.SGD","BK4585","LU1291159041.SGD","BK4559","LU0225284248.USD","LU1074936037.SGD","LU2125154778.USD","LU1868837300.USD","LU1989771016.USD","LU1868836914.USD","LU0061475181.USD","LU2242646821.SGD","LU1670711123.USD","BK4007","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1571399168.USD","LU2133065610.SGD","LU2360032135.SGD","LU1868836591.USD","LU1032466523.USD","LU1585245621.USD","BMY","IE0009355771.USD","LU1868836757.USD","LU2125154935.USD","LU0225771236.USD","BK4581","LU1093756325.SGD","LU1323610961.USD","LU0306806265.USD","IE00BSNM7G36.USD","IE0002141913.USD"],"gpt_icon":0},{"id":"2517444168","title":"J&J - Icotrokinra Results Show Potential to Set a New Standard of Treatment in Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2517444168","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517444168?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:04","pubTimestamp":1741442646,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250308:nFWN3PR08D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","LU2505996509.AUD","LU2129689514.USD","IE00BJJMRZ35.SGD","LU1066051225.USD","BK4532","IE00BVYPNW00.USD","LU0058720904.USD","LU2089984988.USD","LU2430703251.USD","IE00B7SZLL34.SGD","LU0098860793.USD","BK4550","LU1221951046.USD","LU0203347892.USD","LU1674673428.USD","IE0009355771.USD","IE00BVYPNV92.GBP","LU1057294990.SGD","LU0203345920.USD","SG9999002232.USD","BK4504","LU1732799900.SGD","LU1929549753.HKD","LU1032955483.USD","LU0345770993.USD","IE00BFTCPJ56.SGD","SG9999002224.SGD","IE0002270589.USD","BK4568","LU0795875169.SGD","LU1244550221.USD","LU2430703095.HKD","LU1778281490.HKD","BK4581","LU0640476718.USD","IE00B19Z3B42.SGD","LU0466842654.USD","LU0234572021.USD","IE000M9KFDE8.USD","LU1732800096.USD","LU1074936037.SGD","LU0122379950.USD","LU1585245621.USD","BK4559","LU1244550494.USD","BK4588","JNJ","LU2112291526.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2517441682","title":"J&J - Phase 3 Iconic-Advance 1&2(E )Studies Met Their Co-Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2517441682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517441682?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:04","pubTimestamp":1741442646,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250308:nFWN3PR08D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4550","LU1732799900.SGD","BK4559","BK4581","LU2430703095.HKD","BK4588","IE00BVYPNW00.USD","LU0466842654.USD","LU0203347892.USD","LU1066051225.USD","LU1244550494.USD","LU0058720904.USD","LU1221951046.USD","LU0795875169.SGD","LU1929549753.HKD","IE00B7SZLL34.SGD","LU1732800096.USD","LU1674673428.USD","LU0234572021.USD","IE00BFTCPJ56.SGD","LU0345770993.USD","LU2129689514.USD","LU2089984988.USD","JNJ","IE00B19Z3B42.SGD","IE0002270589.USD","IE00BVYPNV92.GBP","LU1074936037.SGD","LU1778281490.HKD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","BK4532","LU1244550221.USD","BK4504","BK4568","LU1585245621.USD","LU2505996509.AUD","LU2112291526.USD","LU0640476718.USD","SG9999002224.SGD","LU0098860793.USD","LU0122379950.USD","LU1057294990.SGD","LU2430703251.USD","SG9999002232.USD","IE000M9KFDE8.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0203345920.USD","LU1032955483.USD"],"gpt_icon":0},{"id":"2517441718","title":"Snowflake’s Stock Dips Amidst AI Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2517441718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517441718?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:03","pubTimestamp":1741442590,"startTime":"0","endTime":"0","summary":"Snowflake ( ($SNOW) ) has fallen by -8.49%. Read on to learn why. Snowflake’s stock experienced a notable decline of 8.49% over the past week, desp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/uncategorized/snowflakes-stock-dips-amidst-ai-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/uncategorized/snowflakes-stock-dips-amidst-ai-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","LU1803068979.SGD","SNOW","BK4535","LU1923623000.USD","LU1951200564.SGD","BK4551","BK4559","LU0889565833.HKD","BK4532","BK4585","LU1951198990.SGD","BK4588","BK4607","BK4505","LU0109392836.USD","BK4613","BK4503","BK4554","BK4581","BK4116"],"gpt_icon":0},{"id":"2517441793","title":"Moderna’s Stock Soars Amid Insider Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2517441793","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517441793?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:02","pubTimestamp":1741442561,"startTime":"0","endTime":"0","summary":"Moderna ( ($MRNA) ) has risen by 17.64%. Read on to learn why. Moderna’s stock has seen a significant rise of 17.64% over the past week, capturing ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/uncategorized/modernas-stock-soars-amid-insider-confidence?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/uncategorized/modernas-stock-soars-amid-insider-confidence?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNA","BK4533","BK4568","BK4501","BK4548","BK4139","BK4585","BK4588","BK4551","BK4532","BK4534"],"gpt_icon":0},{"id":"2517760441","title":"CrowdStrike Holdings Faces Stock Dip Amid Strong Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2517760441","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517760441?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:01","pubTimestamp":1741442504,"startTime":"0","endTime":"0","summary":"CrowdStrike Holdings ( ($CRWD) ) has fallen by -12.86%. Read on to learn why. CrowdStrike Holdings experienced a significant stock price decline of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/uncategorized/crowdstrike-holdings-faces-stock-dip-amid-strong-earnings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/uncategorized/crowdstrike-holdings-faces-stock-dip-amid-strong-earnings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1720051108.HKD","LU2357305700.SGD","BK4551","BK4097","LU2125909759.SGD","IE00B19Z9P08.USD","LU1988902786.USD","LU1923623000.USD","IE00B19Z9Z06.USD","LU1720051017.SGD","LU2211815571.USD","LU2286300806.USD","BK4560","BK4585","LU1064131342.USD","LU1992135399.USD","LU2272731600.USD","LU1923622614.USD","LU1548497426.USD","IE00B894F039.SGD","BK4532","LU2264538146.SGD","BK4528","LU2125909593.SGD","LU0081259029.USD","LU1974910355.USD","LU2106854487.HKD","LU2125909916.SGD","LU2433249047.HKD","LU1923622291.USD","LU1917777945.USD","LU2125909247.SGD","LU1992135472.HKD","LU1951198990.SGD","BK4598","CRWD","LU2023250504.SGD","BK4588","IE00BZ9MQY76.HKD","LU1951200564.SGD","LU2272731782.SGD","BK4543"],"gpt_icon":0},{"id":"2517441677","title":"Incyte - Topline Data From Separate Phase 3 Study, True-Pn2, Showed That Primary Endpoint Did Not Reach Statistical Significance","url":"https://stock-news.laohu8.com/highlight/detail?id=2517441677","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517441677?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:01","pubTimestamp":1741442460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250308:nTUA40P8T6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INCY","BK4550","BK4139","BK4585","BK4588","BK4532"],"gpt_icon":0},{"id":"2517441624","title":"Incyte Corp - Phase 3 True-Pn1 Study Meets All Primary and Key Secondary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2517441624","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517441624?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:01","pubTimestamp":1741442460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250308:nTUA40P8T6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4585","BK4550","BK4532","BK4139","INCY"],"gpt_icon":0},{"id":"2517441510","title":"Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients With Prurigo Nodularis (Pn) at 2025 American Academy of Dermatology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2517441510","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517441510?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:01","pubTimestamp":1741442460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250308:nTUA40P8T6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4139","BK4550","BK4532","INCY","BK4588"],"gpt_icon":0},{"id":"2517744151","title":"Bristol Myers Squibb Presents Late-Breaking Data From Phase 3 Poetyk Psa-2 Trial Demonstrating Superiority of Sotyktu (Deucravacitinib) Compared With Placebo in Adults With Psoriatic Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2517744151","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517744151?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:01","pubTimestamp":1741442460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250308:nTUA3WWKR9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002141913.USD","LU2242646821.SGD","LU0868494617.USD","LU0306807586.USD","IE00BFXG1179.USD","LU1670710588.SGD","IE00B2B36J28.USD","LU0321505868.SGD","LU1670711040.USD","LU0237698245.USD","LU1093756168.USD","BK4581","LU1323610961.USD","LU1585245621.USD","LU2125154935.USD","LU0882574055.USD","BK4559","LU1868836757.USD","LU2125154778.USD","LU1670710661.SGD","LU2133065610.SGD","BMY","BK4585","LU1670711123.USD","LU0096364046.USD","LU0321505439.SGD","LU0985481810.HKD","BK4534","LU1571399168.USD","LU1074936037.SGD","LU1718418525.SGD","LU1989771016.USD","LU1868837300.USD","LU1032466523.USD","LU1868836591.USD","LU2242652126.USD","LU1261432733.SGD","IE0009355771.USD","LU1430594728.SGD","IE00BJT1NW94.SGD","BK4532","BK4007","IE00BFTCPJ56.SGD","LU0225771236.USD","LU1868837136.USD","LU0061475181.USD","BK4588","LU1291159041.SGD","IE00BJJMRZ35.SGD","LU0456855351.SGD"],"gpt_icon":0}],"pageSize":16,"totalPage":125,"pageCount":4,"totalSize":1990}]}}